GleamWall
中文EN

CON Concentra Group Holdings Parent, Inc.

Services-Specialty Outpatient Facilities, NEC · NYSE · SEC CIK 2014596 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY11.8%
TTM net income YoY41.2%
TTM EPS YoY44.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin29.9%
Operating margin16.9%
Net margin9.3%
FCF margin11.0%
EBITDA margin20.3%

Returns

ROE48.5%
ROA7.4%
ROIC (approx.)15.6%
Asset turnover0.80x

Leverage & solvency

Liabilities / assets82.2%
Debt / equity3.00x
Current ratio1.30x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.51x
Accruals ratio-3.8%
Payout ratio14.8%
Capex / revenue3.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31
Income statement
Revenue$2.16B$1.90B$1.84B$1.72B
Cost of revenue$1.55B$1.37B$1.33B$1.24B
Gross profit$613.09M$527.98M$512.43M$481.86M
SG&A expense$203.31M$156.32M$152.00M$149.98M
Operating income$333.99M$304.76M$287.63M$258.53M
Interest expense$109.29M$47.71M$221,000$849,000
Pretax income$223.83M$231.39M$242.63M$224.90M
Income tax$50.98M$59.50M$57.89M$52.65M
Net income$166.41M$166.54M$179.95M$166.73M
EBITDA$409.81M$371.94M$360.68M$332.20M
EPS (basic)1.301.461.731.60
EPS (diluted)1.301.461.731.60
Dividends declared per share0.250.06——
Weighted avg. shares (diluted)128.30M114.20M104.19M103.82M
Balance sheet
Cash & equivalents$79.90M$183.25M$31.37M$37.66M
Receivables$257.90M$217.72M$216.19M—
Current assets$383.10M$437.21M$294.42M—
PP&E, net$225.31M$197.93M$178.37M—
Goodwill$1.48B$1.23B$1.23B$1.23B
Intangibles$242.56M$204.72M$224.77M—
Total assets$2.86B$2.52B$2.33B$2.30B
Current liabilities$337.25M$307.19M$274.63M—
Short-term debt$10.74M$10.09M$1.46M—
Long-term debt$1.56B$1.47B$3.29M—
Total debt$1.57B$1.48B$4.75M—
Total liabilities$2.44B$2.22B$1.16B—
Shareholders' equity$393.28M$275.67M$1.16B$979.34M
Net debt$1.49B$1.30B-$26.63M—
Shares outstanding128.63M128.13M——
Cash flow statement
Operating cash flow$279.40M$274.68M$234.32M$274.34M
Capital expenditure$82.33M$64.33M$64.96M$45.98M
Free cash flow$197.06M$210.35M$169.36M$228.35M
Investing cash flow-$414.86M-$71.27M-$75.31M-$57.75M
Financing cash flow$32.10M-$51.53M-$165.29M-$209.86M
Depreciation & amortization$75.82M$67.18M$73.05M$73.67M
Stock-based compensation$10.49M$2.33M$651,000$2.14M
Dividends paid$32.08M$7.96M$0$0
Share buybacks$22.42M$15.40M$0$0

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.